Eli Lilly Gears Up For Zyprexa Showdown
Eli Lilly & Co. faces its first trial this week over allegations that the pharmaceutical company failed to warn about potential side effects of its schizophrenia medication Zyprexa, in a case...To view the full article, register now.
Already a subscriber? Click here to view full article